Figure 2: A) Fold of LDLr and MDR1A/B gene expression, and B) Fold of CYP3A2 and CYP2C11 gene expression in normolipidemic hepatocytes (NLC), normolipidemic hepatocytes treated with normolipidemic serum (NLC+NLS), normolipidemic hepatocytes treated with hyperlipidemic serum (NLC+HLS), and hyperlipidemic hepatocytes (HLC). One way analysis of variance followed by Dunn's test or Holm-Sidak test were used to assess differences among the groups.* indicates significant difference from NLC.